Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The amount of calories expended after a company PR by "long term investors" to persuade other investors that their investment is a bad idea could fill psychological journals as well as being very amusing.
I couldn't agree more and I am excited about the new strategy. P will move much faster in both phase 2b and 3 trials which will be more lucrative to us and a partner.
$5b would be low if you figure b ABSSSI and P alone could have sales of over $1b each which would be worth over $10b.
Why does it matter where the site is located?
Very interesting! Thanks for the information.
I just don't understand if he is trying to communicate a statement or is he asking a question?
Sorry I didn't see this post! Now I understand the question.
So they don't provide any research into the antibiotic uses. That's what I thought. What's your piont?
What's your take on the information we received in Karen's interview?
Thanks for your efforts. Do you think this is our corporate update?
But in order to partner we need a corporate infrastructure that can carry out the commitments that we make to a partner.
It seems clear to me that our new President is positioning the company for partnerships. This is good news. It will add value quickly.
Well said. Let's raise the level of discourse here.
NR remember the FDA is a government agency. Nothing happens fast. You know that!
Yes! Finally getting some ducks in a row.
6 year old info. Good to know. Thanks
I agree 100% exclamation point
Well said!
I guess it's just part of the process. It's no skin off their back. It's a shame how that system works.
Interesting day on the board. None of the usual negative sentiment. Curious
It is interesting how they pushed the B-UP trial trial ahead so quickly. Hopefully we hear some news on B-OM.
Would it be more beneficial for us to partner each indication for B or sell the platform?
I agree the 2b trial will be quick and cheap and the dividends will be huge.
Nice call!
Sorry I should have used a new post. I definitely agree with what you said.
In the medical industry $440k isn't out of line for a top executive. Sure it's a lot for ctix but it's definitely not out of line.
Oh I get it now! Leo is holding back information. Why didn't you just say that instead of asking a message board a question that only someone at the company could answer?
If you are confused, just ask Leo! Seriously just ask!
Well put! I love all the Google searching and then drawing conclusions based on only partially information. Seriously people, remember there are always two sides to every story.
Google only presents facts.
Well said. Couldn't agree more.
I hate to agree with you but yeah I would love to have more exposure. Yet look at the other stock, it wasn't lasting. Yes, it's painful not to have a higher pps but the science is moving forward!
It was at 14.50 a share for about 50 seconds. Then fell like a rock!
Are the B presentations this weekend or Monday? Thanks
I really liked this part. “Shares of biotech companies are now attractively undervalued as their valuations have dropped 20%-30% over the past 12 months, so I won’t be surprised if M&A deals in the industry start to flourish again,” says Raj Mehra, managing director at Auriga Capital.
I agree 100%. There is no equivocation, no mincing of words. The word was "Robust"
BK, with all of these short quick trials it almost seems to me that Leo is trying to establish a value to the pipeline and to the company overall.
Sorry but I am still stuck on Robust anti-inflammatory properties. To my knowledge he has never said or implied this in the past. They must know something. Very interesting indeed!
Now I am very curious about who he is going to bring on staff. Things are getting getting very interesting.
BK this sentence is exciting and interesting to me because I thought we wouldn't know the inflammation properties of B until the B-OM trial was over.